Trial Outcomes & Findings for Healing Rate of Leg Wounds Treated With Contact and Noncontact Ultrasound: The VIP Ultrasound Protocol (NCT NCT02045303)

NCT ID: NCT02045303

Last Updated: 2022-01-24

Results Overview

Mean and Standard Deviation of the group's total wound area at day one and last treatment day. Wound area was measured as Length x Width. This is to assess the change in area, in order to assess wound progress towards closure.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

11 participants

Primary outcome timeframe

Initial measurement at day 1 and measurement at the subject's last visit at 12 weeks or sooner if the wound closed before then.

Results posted on

2022-01-24

Participant Flow

This study enrolled subjects who had sub-acute or chronic lower leg wound requiring debridement, who were coming to the outpatient wound care clinic for follow up with wound care doctor.

The wound care doctor wrote orders for ultrasound therapy performed by Physical Therapist (PT). Throughout the open enrollment phase, the PT screened referred patients to check if they met study criteria.

Unit of analysis: Wounds

Participant milestones

Participant milestones
Measure
Ambulatory Wound Clinic - Wound Age Between 4 and 21 Weeks
Intervention with contact ultrasound therapy and noncontact ultrasound therapy following the study protocol on subjects receiving care at the wound clinic. Contact Ultrasound Therapy: Following our protocol, the ultrasound wound therapy will start with contact ultrasound until it meets criteria to switch to noncontact ultrasound therapy. Noncontact Ultrasound Therapy: Transition from contact to noncontact ultrasound when criteria for transition is met per our protocol. Wound age between 4 and 21 weeks
Ambulatory Wound Clinic - Wound Age Between 22 and 46 Weeks
Intervention with contact ultrasound therapy and noncontact ultrasound therapy following the study protocol on subjects receiving care at the wound clinic. Contact Ultrasound Therapy: Following our protocol, the ultrasound wound therapy will start with contact ultrasound until it meets criteria to switch to noncontact ultrasound therapy. Noncontact Ultrasound Therapy: Transition from contact to noncontact ultrasound when criteria for transition is met per our protocol. Wound age between 22 and 46 weeks
Ambulatory Wound Clinic - Wound Age >= 47 Weeks
Intervention with contact ultrasound therapy and noncontact ultrasound therapy following the study protocol on subjects receiving care at the wound clinic. Contact Ultrasound Therapy: Following our protocol, the ultrasound wound therapy will start with contact ultrasound until it meets criteria to switch to noncontact ultrasound therapy. Noncontact Ultrasound Therapy: Transition from contact to noncontact ultrasound when criteria for transition is met per our protocol. Wound age \>= 47 weeks
Overall Study
STARTED
6 6
3 10
2 8
Overall Study
COMPLETED
4 4
0 0
2 8
Overall Study
NOT COMPLETED
2 2
3 10
0 0

Reasons for withdrawal

Reasons for withdrawal
Measure
Ambulatory Wound Clinic - Wound Age Between 4 and 21 Weeks
Intervention with contact ultrasound therapy and noncontact ultrasound therapy following the study protocol on subjects receiving care at the wound clinic. Contact Ultrasound Therapy: Following our protocol, the ultrasound wound therapy will start with contact ultrasound until it meets criteria to switch to noncontact ultrasound therapy. Noncontact Ultrasound Therapy: Transition from contact to noncontact ultrasound when criteria for transition is met per our protocol. Wound age between 4 and 21 weeks
Ambulatory Wound Clinic - Wound Age Between 22 and 46 Weeks
Intervention with contact ultrasound therapy and noncontact ultrasound therapy following the study protocol on subjects receiving care at the wound clinic. Contact Ultrasound Therapy: Following our protocol, the ultrasound wound therapy will start with contact ultrasound until it meets criteria to switch to noncontact ultrasound therapy. Noncontact Ultrasound Therapy: Transition from contact to noncontact ultrasound when criteria for transition is met per our protocol. Wound age between 22 and 46 weeks
Ambulatory Wound Clinic - Wound Age >= 47 Weeks
Intervention with contact ultrasound therapy and noncontact ultrasound therapy following the study protocol on subjects receiving care at the wound clinic. Contact Ultrasound Therapy: Following our protocol, the ultrasound wound therapy will start with contact ultrasound until it meets criteria to switch to noncontact ultrasound therapy. Noncontact Ultrasound Therapy: Transition from contact to noncontact ultrasound when criteria for transition is met per our protocol. Wound age \>= 47 weeks
Overall Study
Protocol Violation
2
1
0
Overall Study
Withdrawal by Subject
0
2
0

Baseline Characteristics

Healing Rate of Leg Wounds Treated With Contact and Noncontact Ultrasound: The VIP Ultrasound Protocol

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Wound Age Between 4 and 21 Weeks
n=4 Wounds
Both groups underwent the same protocol of contact ultrasound followed by non-contact ultrasound therapy, with the goal of 3x/week treatment frequency. Study data for this group was collected over a period of 12 weeks or up to the time of wound closure.
Wound Age >=47 Weeks
n=8 Wounds
Both groups underwent the same protocol of contact ultrasound followed by non-contact ultrasound therapy, with the goal of 3x/week treatment frequency. Study data for this group was collected over a period of 12 weeks.
Total
n=12 Wounds
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
2 Participants
n=5 Participants
2 Participants
n=7 Participants
4 Participants
n=5 Participants
Age, Categorical
>=65 years
2 Participants
n=5 Participants
0 Participants
n=7 Participants
2 Participants
n=5 Participants
Sex: Female, Male
Female
1 Participants
n=5 Participants
1 Participants
n=7 Participants
2 Participants
n=5 Participants
Sex: Female, Male
Male
3 Participants
n=5 Participants
1 Participants
n=7 Participants
4 Participants
n=5 Participants
Race/Ethnicity, Customized
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race/Ethnicity, Customized
Black
1 Participants
n=5 Participants
1 Participants
n=7 Participants
2 Participants
n=5 Participants
Race/Ethnicity, Customized
Hispanic or Latino
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race/Ethnicity, Customized
White
3 Participants
n=5 Participants
1 Participants
n=7 Participants
4 Participants
n=5 Participants
Wound Location
Ankle
0 Wounds
n=12 Wounds
1 Wounds
n=8 Wounds
1 Wounds
n=12 Wounds
Wound Location
Foot/Heel/Toes
3 Wounds
n=12 Wounds
2 Wounds
n=8 Wounds
5 Wounds
n=12 Wounds
Wound Location
Knee
0 Wounds
n=12 Wounds
1 Wounds
n=8 Wounds
1 Wounds
n=12 Wounds
Wound Location
Lower Leg
1 Wounds
n=12 Wounds
4 Wounds
n=8 Wounds
5 Wounds
n=12 Wounds
Initial Wound Area
10.12 cm^2
n=12 Wounds
7.93125 cm^2
n=8 Wounds
8.66083 cm^2
n=12 Wounds
Associated Diagnosis
S/p Ganglion Cyst Removal
1 Wounds
n=12 Wounds
0 Wounds
n=8 Wounds
1 Wounds
n=12 Wounds
Associated Diagnosis
Stage IV Pressure Ulcer
1 Wounds
n=12 Wounds
0 Wounds
n=8 Wounds
1 Wounds
n=12 Wounds
Associated Diagnosis
Diabetes
2 Wounds
n=12 Wounds
3 Wounds
n=8 Wounds
5 Wounds
n=12 Wounds
Associated Diagnosis
Peripheral Artery Disease
2 Wounds
n=12 Wounds
0 Wounds
n=8 Wounds
2 Wounds
n=12 Wounds
Associated Diagnosis
Above Knee Amputation (opposite limb)
1 Wounds
n=12 Wounds
0 Wounds
n=8 Wounds
1 Wounds
n=12 Wounds
Associated Diagnosis
Post-Surgical Debridement
1 Wounds
n=12 Wounds
0 Wounds
n=8 Wounds
1 Wounds
n=12 Wounds
Associated Diagnosis
Vasculitis
0 Wounds
n=12 Wounds
3 Wounds
n=8 Wounds
3 Wounds
n=12 Wounds
Associated Diagnosis
Cat Bite
1 Wounds
n=12 Wounds
0 Wounds
n=8 Wounds
1 Wounds
n=12 Wounds
Associated Diagnosis
3rd Degree Burn
0 Wounds
n=12 Wounds
5 Wounds
n=8 Wounds
5 Wounds
n=12 Wounds
Associated Diagnosis
Venous Insufficiency
0 Wounds
n=12 Wounds
5 Wounds
n=8 Wounds
5 Wounds
n=12 Wounds

PRIMARY outcome

Timeframe: Initial measurement at day 1 and measurement at the subject's last visit at 12 weeks or sooner if the wound closed before then.

Mean and Standard Deviation of the group's total wound area at day one and last treatment day. Wound area was measured as Length x Width. This is to assess the change in area, in order to assess wound progress towards closure.

Outcome measures

Outcome measures
Measure
Wound Age Between 4 and 21 Weeks
n=4 Wounds
Wounds age between 4 and 21 weeks at the day of initial visit.
Wound Age >=47 Weeks
n=8 Wounds
Wounds age \>=47 weeks at the day of initial visit.
Total Wound Area
Initial Wound Area
7.93125 Squared centimiters
Standard Deviation 5.96128
7.93125 Squared centimiters
Standard Deviation 5.96128
Total Wound Area
Wound Area on Last Study Visit
1.3275 Squared centimiters
Standard Deviation 2.61515
8.80875 Squared centimiters
Standard Deviation 7.73304

SECONDARY outcome

Timeframe: Initial measurement at day 1 and measurement at the subject's last visit at 12 weeks or sooner if the wound closed before then.

Mean and Standard Deviation of the group's total wound volume at day one and last treatment day. Wound volume was measured as Length x Width X Depth (when able to determine depth). This is to assess the change in volume, in order to assess wound progress towards closure.

Outcome measures

Outcome measures
Measure
Wound Age Between 4 and 21 Weeks
n=4 Wounds
Wounds age between 4 and 21 weeks at the day of initial visit.
Wound Age >=47 Weeks
n=8 Wounds
Wounds age \>=47 weeks at the day of initial visit.
Total Wound Volume
Initial Wound Volume
9.561 cubic centimeter
Standard Deviation 9.94704
2.67475 cubic centimeter
Standard Deviation 2.73782
Total Wound Volume
Wound Volume on Last Study Visit
0.394 cubic centimeter
Standard Deviation 0.78401
2.086 cubic centimeter
Standard Deviation 1.9324

SECONDARY outcome

Timeframe: Day 2 and measurement at the subject's last visit at 12 weeks or sooner if the wound closed before then.

Mean and Standard Deviation of the group's percent adherent and/or non-adherent slough present in the wound bed at day one and last treatment day. This is to assess the change in slough/eschar. This is to determine progression from contact to noncontact ultrasound therapy, as well as to determine progress of wound bed quality.

Outcome measures

Outcome measures
Measure
Wound Age Between 4 and 21 Weeks
n=4 Wounds
Wounds age between 4 and 21 weeks at the day of initial visit.
Wound Age >=47 Weeks
n=8 Wounds
Wounds age \>=47 weeks at the day of initial visit.
Wounds With Slough/Eschar Reduction on Visit 2 and Wounds With Slough/Eschar Reduction at Last Visit
Wounds w/ slough/eschar Reduction on visit 2
4 Wounds
8 Wounds
Wounds With Slough/Eschar Reduction on Visit 2 and Wounds With Slough/Eschar Reduction at Last Visit
Wounds w/ slough/eschar Reduction on last visit
4 Wounds
7 Wounds

OTHER_PRE_SPECIFIED outcome

Timeframe: Initial measurement at day 1 and measurement at the subject's last visit at 12 weeks or sooner if the wound closed before then.

Mean and Standard Deviation of the group's total percent of granulation tissue present in the wound bed at day one and last treatment day. This is to assess the change in granulation, in order to assess progress of wound bed quality.

Outcome measures

Outcome measures
Measure
Wound Age Between 4 and 21 Weeks
n=4 Wounds
Wounds age between 4 and 21 weeks at the day of initial visit.
Wound Age >=47 Weeks
n=8 Wounds
Wounds age \>=47 weeks at the day of initial visit.
Wounds With Granulation Present on Visit 1 and Wounds With Granulation Present at Last Visit
Initial Granulation
22.5 % Granulation
Standard Deviation 17.07825
21.75 % Granulation
Standard Deviation 24.97284
Wounds With Granulation Present on Visit 1 and Wounds With Granulation Present at Last Visit
Granulation on last visit
100 % Granulation
Standard Deviation 0
55.125 % Granulation
Standard Deviation 38.93745

Adverse Events

Wound Age Between 4 and 21 Weeks

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Wound Age >=47 Weeks

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Lisley Viana, Physical Therapist

Texas Health Resources Presbyterian Hospital of Dallas

Phone: 214-345-4334

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place